Single Agent Therapy with Bevacizumab for the Treatment of Atypical Choroid Plexus Tumor

Authors

  • Bharat Malhotra University of Kansas Medical Center:KU School of Medicine-Wichita, 1010 North Kansas, Wichita, KS 67214-3199, USA.
  • Patrick Ters
  • Seth J Page
  • K James Kallail

DOI:

https://doi.org/10.17161/kjm.v8i1.11516

Keywords:

bevacizumab, choroid plexus tumor, antineoplastic agents

Metrics

Metrics Loading ...

Downloads

Published

2015-02-27

Issue

Vol. 8 No. 1 (2015)

Section

Case Reports

License

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Malhotra, B., Ters, P., Page, S. J., & Kallail, K. J. (2015). Single Agent Therapy with Bevacizumab for the Treatment of Atypical Choroid Plexus Tumor. Kansas Journal of Medicine, 8(1), 37-39. https://doi.org/10.17161/kjm.v8i1.11516